Patents by Inventor Robert Saklatvala

Robert Saklatvala has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITIONS OF COMBINATIONS OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS WITH SIMVASTATIN
    Publication number: 20140093564
    Abstract: The present invention is directed to novel pharmaceutical compositions comprising fixed dose combinations of a dipeptidyl peptidase-4 inhibitor (DPP-4 inhibitor), or a pharmaceutically acceptable salt thereof, and simvastatin, or pharmaceutically acceptable salt thereof, methods of preparing such pharmaceutical compositions, and methods of treating Type 2 diabetes and hypercholesterolemia with such pharmaceutical compositions. In particular, the invention is directed to pharmaceutical compositions comprising fixed-dose combinations of sitagliptin phosphate and simvastatin.
    Type: Application
    Filed: June 8, 2012
    Publication date: April 3, 2014
    Applicants: MERCK SHARP & DOHME LTD., Merck Sharp & Dohme Corp
    Inventors: Kathryn Bradley, Richard Elkes, Shaun Fitzpatrick, Robert Saklatvala, Mustafa Mohamed, Richard Kendall
  • PHARMACEUTICAL FORMULATION
    Publication number: 20080275020
    Abstract: The instant invention provides a pharmaceutical composition comprised of a cholesterol absorption inhibitor and an HMG-CoA reductase inhibitor, one or more anti-oxidants, microcrystalline cellulose, hydroxypropyl methylcellulose, magnesium stearate and lactose. The composition need not contain ascorbic acid in order to obtain desirable stability.
    Type: Application
    Filed: March 12, 2008
    Publication date: November 6, 2008
    Inventors: William D. Moore, Shaun Fitzpatrick, Christian Seiler, Robert Saklatvala, Catherine R. Petts, Wing-Kee Philip Cho
  • Pharmaceutical formulation
    Publication number: 20070160666
    Abstract: The instant invention provides a pharmaceutical composition comprised of a cholesterol absorption inhibitor and an HMG-CoA reductase inhibitor, one or more anti-oxidants, microcrystalline cellulose, hydroxypropyl methylcellulose, magnesium stearate and lactose. The composition need not contain ascorbic acid in order to obtain desirable stability.
    Type: Application
    Filed: March 12, 2007
    Publication date: July 12, 2007
    Inventors: William Moore, Shaun Fitzpatrick, Christian Seiler, Robert Saklatvala, Catherine Petts, Wing-Kee Cho
  • Pharmaceutical formulation
    Patent number: 7229982
    Abstract: The instant invention provides a pharmaceutical composition comprised of a cholesterol absorption inhibitor and an HMG-CoA reductase inhibitor, one or more anti-oxidants, microcrystalline cellulose, hydroxypropyl methylcellulose, magnesium stearate and lactose. The composition need not contain ascorbic acid in order to obtain desirable stability.
    Type: Grant
    Filed: July 22, 2003
    Date of Patent: June 12, 2007
    Inventors: William D. Moore, Shaun Fitzpatrick, Christian Seiler, Robert Saklatvala, Catherine R. Petts
  • Pharmaceutical formulation
    Publication number: 20040126423
    Abstract: The instant invention provides a pharmaceutical composition comprised of a cholesterol absorption inhibitor and an HMG-CoA reductase inhibitor, one or more anti-oxidants, microcrystalline cellulose, hydroxypropyl methylcellulose, magnesium stearate and lactose. The composition need not contain ascorbic acid in order to obtain desirable stability.
    Type: Application
    Filed: July 22, 2003
    Publication date: July 1, 2004
    Inventors: William D. Moore, Shaun Fitzpatrick, Christian Seiler, Robert Saklatvala, Catherine R. Petts, Wing-Kee Philip Cho